Ensysce Biosciences Biotech
Funding, team structure (meet the founders), partners and clients
Market - Biotech
Location - San Diego, USA
Description - Ensysce is a clinical stage biotech company committed to stemming the
prescription drug abuse epidemic. Our proprietary prodrug
technologies: abuse resistant TAAP™ and overdose resistant MPAR™ are
designed to improve the care of patients with chronic pain while reducing
the human and economic costs associated with prescription drug abuse.
Tags - PF614 Trypsin Activated Abuse Protection TAAPTM Multi-Pill Abuse Resistance MPARTM
Team
Founder Lynn Kirkpatrick
Founder
Funding
Ensysce Biosciences raised $60,000,000 with GEM Global Yield LLC SCS - 1/1/2021